Everything You Need to Know About Oxidative phosphorylation for Step 1

Oxidative phosphorylation is one of those Step 1 “keystone” topics: it connects biochem energy, toxicology, mitochondrial genetics, and a bunch of classic question stems (cyanide smoke inhalation, aspirin overdose, Leber optic neuropathy). If you can fluently track where the electrons go, where the protons go, and what poisons which step, you’ll pick up a lot of easy points.

What oxidative phosphorylation is (and where it happens)

Oxidative phosphorylation (OxPhos) is the process by which the electron transport chain (ETC) creates a proton gradient across the inner mitochondrial membrane, and ATP synthase uses that gradient to make ATP.

Location: Inner mitochondrial membrane
- ETC complexes sit in the inner membrane
- Protons are pumped from matrix → intermembrane space
Inputs (electron donors):
- NADH (from glycolysis, PDH, TCA, β-oxidation)
- FADH₂ (from TCA via succinate dehydrogenase, and β-oxidation)
Final electron acceptor: O₂ (reduced to H₂O)

Core idea: Electron flow (downhill) powers proton pumping (uphill), creating proton-motive force, which drives ATP production.

The ETC “map” you need for USMLE

Complexes and their jobs (high-yield)

Complex	Also called	Key function	Pumps H⁺?	Inhibited by
I	NADH dehydrogenase	NADH → CoQ	Yes	Rotenone, amytal, piericidin A
II	Succinate dehydrogenase	FADH₂ (succinate → fumarate) → CoQ	No	(Less tested) malonate inhibits SDH enzyme activity
III	Cytochrome bc1	CoQ → cytochrome c	Yes	Antimycin A
IV	Cytochrome c oxidase	Cytochrome c → O₂ (→ H₂O)	Yes	Cyanide, CO, azide, H₂S
V	ATP synthase	H⁺ flow → ATP	—	Oligomycin

Mobile carriers

CoQ (ubiquinone): lipid-soluble carrier between Complex I/II → III
Cytochrome c: water-soluble carrier between Complex III → IV

ATP yield numbers (know the Step 1 conventions)

NADH → ~2.5 ATP
FADH₂ → ~1.5 ATP
Why lower for FADH₂? It enters at Complex II, bypassing Complex I (less proton pumping overall).

💡

First Aid cross-reference: Biochem → Cellular respiration / ETC & inhibitors; also Pharm/Tox tie-ins with cyanide/CO.

Coupling: why electron transport is tied to ATP synthesis

OxPhos is “coupled” because:

ETC activity builds the proton gradient
ATP synthase requires that gradient to phosphorylate ADP

If you block ATP synthase, the gradient becomes so steep that ETC slows/stops (electrons can’t keep flowing if protons can’t be pumped efficiently).

Uncouplers (super testable): “ETC runs, ATP falls, heat rises”

Uncouplers dissipate the proton gradient by allowing H⁺ to leak back into the matrix without generating ATP.

Classic uncouplers

2,4-DNP (dinitrophenol) (toxin/weight loss agent)
High-dose salicylates (aspirin overdose) — acts as an uncoupler early
Thermogenin (UCP1) in brown fat (physiologic uncoupling)

What happens physiologically?

↓ ATP
↑ O₂ consumption (ETC speeds up trying to restore gradient)
↑ heat production (energy lost as heat)
Often ↑ metabolic rate, possible weight loss, hyperthermia

Board-style clue: “Patient is hyperthermic with tachypnea; labs show mixed acid-base issues in salicylate toxicity; mitochondria consuming oxygen but ATP low.”

💡

First Aid cross-reference: Uncouplers, brown fat/thermogenin, aspirin toxicity.

Inhibitors: where the chain breaks (and what changes clinically)

Complex IV inhibitors: cyanide, CO, azide (biggest clinical hit)

Cyanide binds cytochrome c oxidase (Complex IV) → prevents O₂ reduction
Effect: electron transport halts → no proton pumping → no ATP via OxPhos
Tissue hypoxia with normal PaO₂: oxygen is present but can’t be utilized (histotoxic hypoxia)

Key clinical/lab associations

Severe lactic acidosis (cells shift to anaerobic glycolysis)
High venous O₂ content (tissues can’t extract O₂)
Symptoms: headache, confusion, seizures, cardiovascular collapse

Treatment (cyanide)

Hydroxocobalamin (binds cyanide → cyanocobalamin)
Alternative/adjunct (depending on setting): nitrites + thiosulfate
- Nitrites induce methemoglobin to “soak up” cyanide
- Thiosulfate helps conversion to thiocyanate

Complex I / III inhibitors (classics)

Complex I: rotenone, amytal
Complex III: antimycin A
These are more commonly tested as “which complex is inhibited” rather than management emergencies.

ATP synthase inhibitor

Oligomycin inhibits Complex V
Effect: ATP synthase stops → proton gradient rises → ETC slows/stops secondarily

Pathophysiology: what fails when OxPhos fails

When oxidative phosphorylation is impaired (by toxins, ischemia, or mitochondrial disease):

ATP drops
- High-energy tissues are hit first: brain, skeletal muscle, heart, retina
Cells shift to anaerobic glycolysis
- ↑ lactate → lactic acidosis
Reactive oxygen species (ROS) may rise
- Electron “leak” → superoxide formation (especially when ETC is dysfunctional)

ROS tie-in (frequently integrated)

ROS damage lipids, proteins, DNA
Defenses:
- Superoxide dismutase: $O_2^- \to H_2O_2$
- Catalase / glutathione peroxidase: $H_2O_2 \to H_2O$
High-yield deficiency association: G6PD deficiency → ↓ NADPH → ↓ reduced glutathione, making RBCs vulnerable to oxidative stress (not an OxPhos disorder, but commonly cross-tested alongside oxidative injury concepts)

Clinical presentation: how Step questions describe OxPhos problems

General presentation patterns

Exercise intolerance, muscle weakness
Neurologic issues: seizures, developmental delay, stroke-like episodes
Cardiomyopathy
Vision/hearing issues (retina/optic nerve = high ATP demand)
Unexplained lactic acidosis, especially with minimal hypoperfusion

High-yield mitochondrial diseases linked to OxPhos (Step favorites)

Leber hereditary optic neuropathy (LHON)

Painless, subacute central vision loss (young adult)
Mitochondrial DNA mutations affecting ETC (classically Complex I genes)
Maternal inheritance

MELAS

Mitochondrial Encephalomyopathy, Lactic Acidosis, Stroke-like episodes
Seizures, episodic neurologic deficits, elevated lactate
Maternal inheritance (heteroplasmy explains variable severity)

MERRF

Myoclonic Epilepsy with Ragged Red Fibers
Myoclonus, seizures, muscle biopsy findings

USMLE inheritance pearl

All children of an affected mother may inherit mtDNA mutations (variable expression due to heteroplasmy).
Affected fathers do not transmit mtDNA disorders.

💡

First Aid cross-reference: Mitochondrial disorders, maternal inheritance, heteroplasmy.

Diagnosis: what clues confirm OxPhos dysfunction?

Labs and bedside clues

Elevated lactate (± elevated alanine) without clear shock/hypoxemia
High venous O₂ saturation in cyanide poisoning (oxygen delivery okay, utilization impaired)
Metabolic acidosis with increased anion gap: $\text{Anion gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-)$

Specialized tests (more Step 1 conceptual than Step 2 practical)

Muscle biopsy: “ragged red fibers” in some mitochondrial myopathies
Genetic testing for mtDNA mutations
Enzyme assays / respirometry in specialized contexts

Treatment principles (Step 1 + Step 2 relevance)

Toxin-specific

Cyanide: hydroxocobalamin (key), supportive care, consider nitrite/thiosulfate protocols
CO poisoning: 100% oxygen ± hyperbaric oxygen (ties to Complex IV functional inhibition and hypoxia themes)
Salicylate toxicity: alkalinize serum/urine, supportive care, possible dialysis (and remember its uncoupling effect contributes to hyperthermia)

Mitochondrial disorders (supportive, high-yield “what’s realistic”)

Avoid triggers that worsen energy deficits (fasting, certain meds depending on disorder)
Supportive management (nutrition, seizure control)
Some patients receive “mitochondrial cocktails” (e.g., riboflavin, CoQ10) — evidence varies; Step exams usually emphasize supportive care + genetics rather than a single curative therapy.

High-yield associations & favorite question stems

Rapid fire: match the stem to the mechanism

House fire + altered mental status + severe lactic acidosis → think cyanide (Complex IV inhibition)
Cherry-red skin (classic), bright red venous blood, high venous O₂ → cyanide pattern (utilization failure)
Weight loss drug + hyperthermia + ↑ O₂ consumption + ↓ ATP → 2,4-DNP uncoupling
Brown fat in newborns → thermogenin (UCP1) uncouples to generate heat
Painless central vision loss in young man + maternal inheritance → LHON
Stroke-like episodes + lactic acidosis + maternal inheritance → MELAS

“Block vs uncouple” summary table (gold for test day)

Feature	ETC inhibitor (e.g., cyanide)	Uncoupler (e.g., DNP, aspirin)
Electron transport	Stops	Continues/increases
Proton gradient	Decreases (not generated)	Decreases (dissipated)
ATP	Decreases	Decreases
O₂ consumption	Decreases	Increases
Heat	Variable/low	Increases

Use these as anchor points while you annotate:

Electron transport chain complexes + inhibitors (rotenone/amytal/antimycin A/cyanide/CO/oligomycin)
Uncouplers (DNP, aspirin toxicity, thermogenin in brown fat)
Mitochondrial inheritance + diseases (LHON, MELAS, MERRF, heteroplasmy)
Hypoxia types (histotoxic hypoxia with cyanide)
Lactic acidosis pathways and clinical contexts

Exam-day takeaways (what to remember under time pressure)

O₂ is the final electron acceptor at Complex IV.
Complex II doesn’t pump protons → FADH₂ yields less ATP than NADH.
Uncouplers increase O₂ consumption but decrease ATP (and generate heat).
Cyanide/CO/azide hit Complex IV → profound lactic acidosis + high venous O₂.
Mitochondrial diseases = maternal inheritance, high-energy organs affected, often lactic acidosis.